Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Consolidates RNA, Proteomics, Reagents Businesses

NEW YORK, March 5 (GenomeWeb News) - Agilent Technologies has consolidated into a single corporate division its gene-expression, proteomics, and reagents businesses, the company said today.

 

The newly formed Integrated Biology Solutions unit will reside within Agilent's Life Sciences and Chemical Analysis business group. Fran DiNuzzo, vice president of the bio-reagents, consumables, and services, will oversee the new division, Agilent said.
 
The unit, modeled on the systems biology approach, will "provide a single interface through which Agilent can better serve its customers in basic research, drug discovery and early-stage drug development," said DiNuzzo, whose new title is vice president and general manager of IBS. He also said the division will "enable" Agilent to better develop new products "that bridge multiple disciplines."

 

Christina Maehr, a spokeswoman for Agilent, told GenomeWeb News that the company has no current plans to eliminate any positions. "This move is not an attempt to cut back" on spending, she said. Additionally, she said the company is "hiring for several positions," including industry marketing manager.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.